Tell your doctor if you have the following symptoms: pain in the chest, groin, or legs, especially the calves, difficulty with breathing, severe, sudden headache, slurred speech, sudden, unexplained shortness of breath, sudden loss of coordination, sudden, severe weakness or numbness in the arm or leg, or vision changes. This medicine may increase your risk of blood clots. Blood tests will be needed to check for unwanted effects. This will allow your doctor to see if the medicine is working properly. Your doctor will check your progress closely while you are receiving this medicine. This medicine is given through a needle placed in one of your veins. Hereditary fructose intolerance-This medicine contains sorbitol, which may increase risk for more serious side effects.Ī nurse or other trained health professional will give you this medicine in a hospital. Make sure you tell your doctor if you have any other medical problems, especially:īlood clots, history of-Use with caution. The presence of other medical problems may affect the use of this medicine.

Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Other InteractionsĬertain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter ) medicine.

In these cases, your doctor may want to change the dose, or other precautions may be necessary.

Drug InteractionsĪlthough certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. GeriatricĪppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of idarucizumab injection in the elderly. Safety and efficacy have not been established. Appropriate studies have not been performed on the relationship of age to the effects of idarucizumab injection in the pediatric population.

Praxbind dose